SOURCE: Industrial Info Resources

August 27, 2007 08:01 ET

No Morning After Blues for Barr Pharmaceuticals as 2007 Plan B Sales Top $80 Million, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - August 27, 2007) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Drugs by their very nature are controversial. No matter what medical issues they attempt to treat, there is invariably some resistance or opposition to their use. Some provoke an extremely vociferous response from both supporters and detractors, as is the case with Plan B, or the "morning after" pill. Marketed by Duramed, a division of Barr Pharmaceuticals Incorporated (NYSE:BRL), the drug was approved by the Food and Drug Administration (FDA) in 2006 for the over-the-counter sale to consumers age 18 and above.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at http://www.industrialinfo.com/showNews.jsp?newsitemID=118451, or browse other breaking industrial news stories at www.industrialinfo.com.

Industrial Info Resources (IIR) provides marketing communication services ranging from industrial database solutions to market forecasting, custom analytics, and specialty promotions that support high-level image campaigns. For more information send inquiries to pharmabiogroup@industrialinfo.com or visit us at www.industrialinfo.com.

Contact Information

  • Contact:
    Joe Govreau
    713-783-5147